Weight loss drugs welcome policy turning point: US Medicaid coverage of GLP-1.

According to Zhtng Cijng APP, following the Trump administration reaching a pricing agreement, the Centers for Medicare & Medicaid Services (CMS) announced on Tuesday the launch of a voluntary program to include GLP-1 class weight loss and diabetes treatment drugs in the coverage scope of Medicaid and Medicare Part D.